The goal of this project is to develop accessible and effective methods to discover the interaction partners of proteins that are modified with O-linked beta-N-acetylglucosamine (O-GlcNAc). O-GlcNAc is a common post- translational modification of intracellular proteins in metazoa and higher plants. Hundreds of O-GlcNAc- modified nuclear and cytoplasmic proteins have been identified. Although O-GlcNAc is both abundant and essential, little is known about how it affects the function of modified proteins. The central hypothesis of the proposed work is that O-GlcNAc-modified proteins are surrounded by a different set of molecules than the unmodified proteins. Obtaining information about the interaction partners of O-GlcNAc-modified proteins will provide new insight into O-GlcNAc function. To identify O-GlcNAc interaction partners, we will rely on a photocrosslinking approach to convert low-affinity glycan-dependent interactions to high-affinity covalent complexes that can be purified and characterized by mass spectrometry. Two complementary approaches will be pursued: an in-lysate photocrosslinking approach (Aim 1) and an in-cell photocrosslinking approach (Aim 2). In the first aim, a panel of photocrosslinking glycopeptide probes will be prepared. These molecules will be crosslinked to proteins in lysate. The crosslinked complexes will be isolated and the interaction partners will be identified by mass spectrometry. The outcome of this aim will be an in-lysate photocrosslinking method that has the following features: (a) probe molecules produced by routine, simple methods, (b) probe molecules crosslinked efficiently and specifically to interacting proteins, (c) LC-MS/MS delivering a high yield of tryptic peptides from a specific subset of proteins, and (d) candidate interacting proteins confirmed by in vitro and cell-based assays. In the second aim, a photocrosslinking functional group will be incorporated onto O-GlcNAc residues in living cells. Subsequent UV irradiation will result in covalent crosslinking of O-GlcNAc-associated interactions in their native cellular context. As in Aim 1, the crosslinked complexes will be isolated and the interaction partners will be identified by mass spectrometry. The basic features of this in-cell photocrosslinking method have already been reported;
the aim of this proposal is to make the method more effective and powerful by (a) engineering cells to produce more O-GlcNDAz, (b) purifying crosslinked material more efficiently and stringently, and (c) improving confidence in candidate hit identification. The reagents and methods developed will be shared with other research groups to enable study of a wide variety of O-GlcNAc- modified proteins with diverse biological functions. The proposed work places a high priority on approaches that are simple to implement and make use of ?off-the-shelf? reagents and procedures. Making these methods available to the broad biomedical community is significant because dysregulation of O-GlcNAc is associated with multiple disease states including type II diabetes, cardiovascular disease, Alzheimer's disease, and several cancers.

Public Health Relevance

Alterations in O-GlcNAc, an essential and abundant post-translational modification of proteins, are associated with neurogenerative diseases, type II diabetes, and cancer. Yet the ways in which O-GlcNAc affects the functions of modified proteins remain poorly understood. We will develop easy-to-use photocrosslinking tools to discover binding partners of O-GlcNAc-modified nucleoporins, thereby providing insight into O-GlcNAc function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21DK112733-01
Application #
9166533
Study Section
Special Emphasis Panel (ZRG1-IMST-L (50)R)
Program Officer
Sechi, Salvatore
Project Start
2016-07-25
Project End
2018-06-30
Budget Start
2016-07-25
Budget End
2017-06-30
Support Year
1
Fiscal Year
2016
Total Cost
$314,119
Indirect Cost
$120,119
Name
University of Texas Sw Medical Center Dallas
Department
Biochemistry
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Toleman, Clifford A; Schumacher, Maria A; Yu, Seok-Ho et al. (2018) Structural basis of O-GlcNAc recognition by mammalian 14-3-3 proteins. Proc Natl Acad Sci U S A 115:5956-5961
Park, Sung-Kyun; Zhou, Xiaorong; Pendleton, Kathryn E et al. (2017) A Conserved Splicing Silencer Dynamically Regulates O-GlcNAc Transferase Intron Retention and O-GlcNAc Homeostasis. Cell Rep 20:1088-1099
Kohler, Jennifer J (2017) Carb cutting works better with a partner. Nat Struct Mol Biol 24:433-435